The Medicines Company announces that the ORION-10 study of inclisiran showed durable and potent lowering of LDL-C

The Medicines Company announces that the ORION-10 study of inclisiran showed durable and potent lowering of LDL-C. Photo: courtesy of PublicDomainPictures from Pixabay.